Role of Immunomarkers in Diagnosis of Lung Carcinomas Using Small Lung Biopsies

Authors

  • Ali kamel daod

Abstract

A small lung biopsy through the bronchi is  considered the main method to diagnose most of lung carcinomas. It`s essential to identify the different types of primary and metastatic lung carcinomas in order to apply the appropriate chemical and targeted therapies which depend in their efficacy on the accurate diagnosis of the type of the tumors.

This study aims to determine the role of a selected  group of immunohistochemical markers in confirming the diagnosis of primary lung carcinomas and distinguishing them from the metastatic ones.

The study was performed  on 145 small pulmonary biopsies, taken from the archive of department of pathology at Tishreen University Hospitalin Lattakia. All biopsies were stained with H&E and diagnosed depending of the histologic and morphologic standards. Then the selected immunohistochemical stainings  ( P63 / p40, CD56, Chromogranin A, TTF1, Napsin-A, CK7, CK5 / 6, Desmoglin-3) were applied. The histomorphologic features were approached with the results of immunohistochemistry .

The study showed that confirming the diagnosis of lung cancers requires the application of appropriate immunological markers, especially the poorly differentiated tumors. The compination of TTF1 with Napsin-A increased the diagnostic accuracy of adenocarcinoma from 75% to 95% . Furthermore, the combination of Desmoglin-3, with P63/P40 confirms thediagnosis of squamous cell carcinoma .Nonsmall cell lung carcinomas are a heterogeneous group that includes different tumors, which are distinguished with immunohistochemical markers

 

تعتبر الخزعة الرئوية الصغيرة التنظيرية عبر القصبات هي الوسيلة الرئيسية لتشخيص معظم سرطانات الرئة.   تمييز مختلف أنماط السرطانات الرئوية البدئية والنقيلية مهم من أجل تطبيق المعالجة الكيميائية والعلاجات الهدفية التي يتوقف نجاحها على تحديد النمط الخلوي للورم بدقة.

تهدف الدراسة تحديد دور مجموعة انتقائية من الواسمات المناعية في تأكيد تشخيص السرطانات الرئوية البدئية وتمييزها عن النقائل.

أجريت الدراسة على 145 خزعة رئوية صغيرة من ارشيف مخبر التشريح المرضي في مشفى تشرين الجامعي باللاذقية. شخصت جميع العينات بالاعتماد على المعايير النسيجية والمورفولوجية وبطريقة التلوين الروتيني بـ H&E , ثم طبقت الواسمات المناعية المنتقاة    P63/p40, CD56, Chromogranin A, TTF1, Napsin-A, CK7,CK5/6, Desmoglin-3 . تمت مقاربة العلامات المورفولوجية النسيجية لكل ورم مع نتائج الواسمات المناعية.

بينت الدراسة أن تأكيد تشخيص سرطانات الرئة يتطلب تطبيق الواسمات المناعية المناسبة وخاصة الحالات القليلة التمايز. ترفع مشاركة TTF1, مع Napsin-A دقة تشخيص السرطان الغدي الرئوي من 75% إلى 95% , وأن مشاركة  Desmoglin-3مع P63/p40,  تؤكد تشخيص السرطان شائك الخلايا. المجموعة المسماة سرطانات غير صغيرة الخلايا هي مجموعة متغايرة تضم أوراما مختلفة يتم تمييزها بواسطة الواسمات المناعية.

Downloads

Published

2019-12-24

How to Cite

1.
daod A kamel. Role of Immunomarkers in Diagnosis of Lung Carcinomas Using Small Lung Biopsies. Tuj-hlth [Internet]. 2019Dec.24 [cited 2024Apr.24];41(6). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/9337

Issue

Vol. 41 No. 6 (2019): MEDICAL SCIENCES SERIES

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.